Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $47.1950 (-2.67%) ($47.1950 - $47.1950) on Thu. Jul. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.67% (three month average) | RSI | 53 | Latest Price | $47.1950(-2.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.2% a day on average for past five trading days. | Weekly Trend | HALO advances 3.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(44%) IWO(39%) IWM(38%) IWN(37%) IWC(36%) | Factors Impacting HALO price | HALO will decline at least -1.335% in a week (0% probabilities). VIXM(-15%) UUP(-8%) VXX(-6%) TBT(-3%) GLD(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.335% (StdDev 2.67%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $49.4(-4.46%) | 10 Day Moving Average | $47.95(-1.57%) | 20 Day Moving Average | $46.8(0.84%) | To recent high | -8.9% | To recent low | 26.3% | Market Cap | $6.45b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |